Approach to the Patient with Suspected Renal Artery Stenosis

Chapter

Abstract

Atherosclerosis is the underlying mechanism of 90 % of all renal artery stenosis (RAS). There remains a great variability in response to blood pressure control and/or kidney function with percutaneous RAS intervention. Patient selection to determine those who will benefit the most from renal revascularization is the key to correct management of this complex disease state. The purpose of this chapter is to describe an approach to RAS that takes epidemiology, demographics, and kidney function into account prior to intervention.

Keywords

Catheter Filtration Ischemia Creatinine Aspirin 

References

  1. 1.
    Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431–42.PubMedCrossRefGoogle Scholar
  2. 2.
    Hansen KJ, Edwards MS, Craven TE, Cherr G, Jackson S, Appel R, Burke G, Dean R. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36:443–51.PubMedCrossRefGoogle Scholar
  3. 3.
    Conlon PJ, Little MA, Pieper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001;60:1490–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Rihal CS, Textor SC, Breen JF, McKusick MA, Grill DE, Hallett JW, Holmes DR. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc. 2002;77:309–16.PubMedCrossRefGoogle Scholar
  5. 5.
    Olin JW, Melia M, Young JR, Graor RA, Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990;88:46N–51N.PubMedCrossRefGoogle Scholar
  6. 6.
    Caps MT, Perissinotto C, Zierler RE, Polissar NL, Bergelin RO, Tullis MJ, Cantwell-Gab K, Davidson RC, Strandness Jr DE. Prospective study of atherosclerotic disease progression in the renal artery. Circulation. 1998;98:2866–72.PubMedCrossRefGoogle Scholar
  7. 7.
    Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am. 1984;11(3):383–392.PubMedGoogle Scholar
  8. 8.
    Van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000;342:1007–14.PubMedCrossRefGoogle Scholar
  9. 9.
    Dean RH, Kieffer RW, Smith BM, Oates JA, Nadeau JHJ, Hollifield JU, DuPont WD. Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch Surg. 1981;116:1408–15.PubMedCrossRefGoogle Scholar
  10. 10.
    Scoble JE, Maher ER, Hamilton G, Dick R, Sweny P, Moorhead JF. Atherosclerotic renovascular disease causing renal impairment—a case for treatment. Clin Nephrol. 1989;31:119–22.PubMedGoogle Scholar
  11. 11.
    Simon P, Benarbia S, Charasse C, Stanescu C, Boulahrouz R, Le Cacheux P, Ang KS, Ramée MP. Ischemic renal diseases have become the most frequent causes of end stage renal disease in the elderly. Arch Mal Coeur Vaiss. 1998;91:1065–8.PubMedGoogle Scholar
  12. 12.
    Epstein FH. Oxygen and renal metabolism. Kidney Int. 1997;51:381–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Yune HY, Klatte EC. Collateral circulation to an ischemic kidney. Radiology. 1976;119:539–46.PubMedGoogle Scholar
  14. 14.
    Kontogiannis J, Burns KD. Role of AT1 angiotensin II receptors in renal ischemic injury. Am J Physiol. 1998;274(1 Pt 2):F79–90.PubMedGoogle Scholar
  15. 15.
    Lerman L, Textor SC. Pathophysiology of ischemic nephropathy. Urol Clin North Am. 2001;28:793–803, ix.PubMedCrossRefGoogle Scholar
  16. 16.
    Matsusaka T, Hymes J, Ichikawa I. Angiotensin in progressive renal diseases: theory and practice. J Am Soc Nephrol. 1996;7:2025–43.PubMedGoogle Scholar
  17. 17.
    Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C. Increased oxidative stress in experimental renovascular hypertension. Hypertension. 2001;37(2 Part 2):541–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation. 2005;112:1362–74.PubMedCrossRefGoogle Scholar
  19. 19.
    Sadowski EA, Bennett LK, Chan MR, Wentland AL, Garrett AL, Garrett RW, Djamali A. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology. 2007;243:148–57. Epub 2007 Jan 31.PubMedCrossRefGoogle Scholar
  20. 20.
    Textor SC, Wilcox CS. Renal artery stenosis: a common, treatable cause of renal failure? Annu Rev Med. 2001;52:421–42.PubMedCrossRefGoogle Scholar
  21. 21.
    Yevzlin AS, Schoenkerman AB, Gimelli G, Asif A. Arterial interventions in arteriovenous access and chronic kidney disease: a role for interventional nephrologists. Semin Dial. 2009;22:545–56.PubMedCrossRefGoogle Scholar
  22. 22.
    Hegde U, Rajapurkar M, Gang S, Khanapet M, Durugkar S, Gohel K, Aghor N, Ganju A, Dabhi M. Fifteen years experience of treating atherosclerotic renal artery stenosis by interventional nephrologists in India. Semin Dial. 2012;25:97–104.PubMedCrossRefGoogle Scholar
  23. 23.
    Bax L, Woittiez AJ, Kouwenberg HJ, Mali WP, Buskens E, Beek FJ, Braam B, Huysmans FT, Schultze Kool LJ, Rutten MJ, Doorenbos CJ, Aarts JC, Rabelink TJ, Plouin PF, Raynaud A, van Montfrans GA, Reekers JA, van den Meiracker AH, Pattynama PM, van de Ven PJ, Vroegindeweij D, Kroon AA, de Haan MW, Postma CT, Beutler JJ. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150(12):840–8, W150–1.PubMedCrossRefGoogle Scholar
  24. 24.
    The ASTRAL, Investigators T. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953–62.CrossRefGoogle Scholar
  25. 25.
    Cooper CJ, Murphy TP, Matsumoto A, et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J. 2006;152:59–66.PubMedCrossRefGoogle Scholar
  26. 26.
    Zeller T, Muller C, Frank U, Burgelin K, Horn B, Schwarzwalder U, Cook-Bruns N, Neumann FJ. Stent angioplasty of severe atherosclerotic ostial renal artery stenosis in patients with diabetes mellitus and nephrosclerosis. Catheter Cardiovasc Interv. 2003;58:510–5.PubMedCrossRefGoogle Scholar
  27. 27.
    Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski M, Koch KM, Haller H. Use of Doppler ultrasonography to predict the outcome of therapy for renal artery stenosis. N Engl J Med. 2001;344:410–7. Krijnen P, van Jaarsveld BC, Deinum J, Steyerberg EW, Habbema JD. Which patients with hypertension and atherosclerotic renal artery stenosis benefit from immediate intervention? J Hum Hypertens. 2004;18:91–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Hegde U, Rajapurkar M, Gang S, Khanapet M, Durugkar S, Gohel K, Aghor N, Ganju A, Dabhi M. Fifteen years experience of treating atherosclerotic renal artery stenosis by interventional nephrologists in India. Semin Dial. 2012;25(1):101–4.Google Scholar
  29. 29.
    Yevzlin AS. Comprehensive renal artery stenosis management by nephrology: a more selective approach. Semin Dial. 2012;25(1):105–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Fisher JEE, Olin JW. Renal artery stenosis: clinical evaluation. In: Creager MA, Loscalzo J, editors. Vascular medicine: a companion to Braunwald’s heart disease. 1st ed. Philadelphia: Saunders/Elsevier; 2006. p. 335–47.CrossRefGoogle Scholar
  31. 31.
    Mukherjee D, Bhatt DL, Robbins M, Roffi M, Cho L, Reginelli J, Bajzer C, Navarro F, Yadav JS. Renal artery end-diastolic velocity and renal artery resistance index as predictors of outcome after renal stenting. Am J Cardiol. 2001;88(9):1064–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Schreier DZ, Weaver FA, Frankhouse J, Papanicolaou G, Shore E, Yellin AE, Harvey F. A prospective study of carbon dioxide-digital subtraction vs standard contrast arteriography in the evaluation of the renal arteries. Arch Surg. 1996;131:503–7; discussion 507–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Weibull H, Bergqvist D, Bergentz SE, Jonsson K, Hulthen L, Manhem P. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg. 1993;18:841–50; discussion 850–2.PubMedCrossRefGoogle Scholar
  34. 34.
    Xue F, Bettmann MA, Langdon DR, Wivell WA. Outcome and cost comparison of percutaneous transluminal renal angioplasty, renal arterial stent placement, and renal arterial bypass grafting. Radiology. 1999;212:378–84.PubMedCrossRefGoogle Scholar
  35. 35.
    Bettmann MA, Dake MD, Hopkins LN, Katzen BT, White CJ, Eisenhauer AC, Pearce WH, Rosenfield KA, Smalling RW, Sos TA, Venbrux AC. Atherosclerotic vascular disease conference: Writing Group VI: revascularization. Circulation. 2004;109:2643–50.PubMedCrossRefGoogle Scholar
  36. 36.
    Gruntzig A, Kuhlmann U, Vetter W, Lutolf U, Meier B, Siegenthaler W. Treatment of renovascular hypertension with percutaneous transluminal dilatation of a renal-artery stenosis. Lancet. 1978;1:801–2.PubMedCrossRefGoogle Scholar
  37. 37.
    Tegtmeyer CJ, Elson J, Glass TA, Ayers CR, Chevalier RL, Wellons Jr HA, Studdard Jr WE. Percutaneous transluminal angioplasty: the treatment of choice for renovascular hypertension due to fibromuscular dysplasia. Radiology. 1982;143:631–7.PubMedGoogle Scholar
  38. 38.
    Van De Ven PJ, Kaatee R, Beutler JJ, Kaatee R, Beek FJ, Mali WP, Koomans HA. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999;353:282–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Leertouwer TC, Gussenhoven EJ, Bosch JL, Van Jaarsveld BC, Van Dijk LC, Deinum J. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology. 2000;216:78–85. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. QJM. 1999;92:159–67.PubMedCrossRefGoogle Scholar
  40. 40.
    Rocha-Singh K, Jaff MR, Rosenfield K. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol. 2005;46:776–83.PubMedCrossRefGoogle Scholar
  41. 41.
    Feldman RL, Wargovich TJ, Bittl JA. No-touch technique for reducing aortic wall trauma during renal artery stenting. Catheter Cardiovasc Interv. 1999;46:245–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Division of Nephrology, Department of Medicine (CHS)University of WisconsinMadisonUSA
  2. 2.Division of Nephrology, Department of MedicineUniversity of Wisconsin College of Medicine and Public HealthMadisonUSA

Personalised recommendations